Citation Impact
Citing Papers
Topographical and Temporal Diversity of the Human Skin Microbiome
2009 StandoutScience
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
FRAX™ and the assessment of fracture probability in men and women from the UK
2008 Standout
Bone density at various sites for prediction of hip fractures
1993 Standout
Opioid Use for Noncancer Pain and Risk of Fracture in Adults: A Nested Case-Control Study Using the General Practice Research Database
2013
Clinician’s Guide to Prevention and Treatment of Osteoporosis
2014 Standout
The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis
2010 Standout
Osteoporosis
2019 Standout
The burden of hospitalised fractures in Sweden
2004
IL-31: A new link between T cells and pruritus in atopic skin inflammation
2006 Standout
The economic and human costs ofosteoporotic fracture
1995
Psoriasis
2009 Standout
Effects of caffeine on human health
2003 Standout
Pathogenesis and clinical features of psoriasis
2007 Standout
Autoimmune Diseases
2001
Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis
2007
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
2008 Standout
Pathogenesis and therapy of psoriasis
2007 StandoutNature
Diagnosis of osteoporosis and assessment of fracture risk
2002 Standout
Transcriptional regulation by calcium, calcineurin, and NFAT
2003 Standout
Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways
2008
Prediction of fracture from low bone mineral density measurements overestimates risk
2000
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes
2006 Standout
Development, cytokine profile and function of human interleukin 17–producing helper T cells
2007 Standout
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Impact near the hip dominates fracture risk in elderly nursing home residents who fall
1993
Serum Levels of TNF‐α, IFN‐γ, IL‐6, IL‐8,IL‐12, IL‐17, and IL‐18 in Patients With Active Psoriasis andCorrelation With Disease Severity
2005 Standout
Osteoporosis: now and the future
2011 Standout
Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark
2004
Fracture Reduction Affects Medicare Economics (FRAME): Impact of increased osteoporosis diagnosis and treatment
2005
Efficacy of a New Tonic Containing Urea, Lactate, Polidocanol, and <b><i>Glycyrrhiza inflata</i></b> Root Extract in the Treatment of a Dry, Itchy, and Subclinically Inflamed Scalp
2013 Standout
Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities
2004
Psoriasis
2015 Standout
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
2006 Standout
Psoriasis: emerging therapeutic strategies
2005
Localization of Calcineurin/NFAT in Human Skin and Psoriasis and Inhibition of Calcineurin/NFAT Activation in Human Keratinocytes by Cyclosporin A
2002
Cost-Effectiveness of Preventing Hip Fracture in the General Female Population
2001
Cost Effectiveness of Screening Perimenopausal White Women for Osteoporosis: Bone Densitometry and Hormone Replacement Therapy
1990
Nerve Growth Factor in Rheumatic Diseases
2009
World-wide Projections for Hip Fracture
1997 Standout
Fracture risk associated with the use of morphine and opiates
2006
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report
1994 Standout
Animal models for implant biomaterial research in bone: A review
2007 Standout
Immunopathogenesis of Psoriasis
2007
Innate and adaptive immunity and the pathophysiology of psoriasis
2006
Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>
1998 Standout
Osteoporosis. Frequency, consequences, and risk factors
1996
Effect and Offset of Effect of Treatments for Hip Fracture on Health Outcomes
1999
The immunologic basis for the treatment of psoriasis with new biologic agents
2002
Costs and health effects of osteoporotic fractures
1994
The incidence of hip fracture in Europe
1993
The costs of fatal and non-fatal falls among older adults
2006 Standout
Transdermal delivery of drugs for the treatment of bone diseases
2000
Epidemiology of hip fractures: Implications of the exponential increase with age
1996
Coffee and Health: A Review of Recent Human Research
2006 Standout
Psoriasis
2005
The evaluation of psoriasis therapy with biologics leads to a revision of the current view of the pathogenesis of this disorder
2006
Hip fractures in the elderly: A world-wide projection
1992 Standout
Epidemiology and outcomes of osteoporotic fractures
2002 Standout
Caffeine and Other Predictors of Bone Density among Pre- and Perimenopausal Women
1993
Prevention of falls and consequent injuries in elderly people
2005 Standout
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
2006 StandoutNature
Incidence of clinically diagnosed vertebral fractures: A population-based study in rochester, minnesota, 1985-1989
1992 Standout
Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities
2004
A Model of Lifetime Osteoporosis Impact
1991
Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis
2000 Standout
Prevention of Nonvertebral Fractures by Alendronate
1997
Methodology for Estimating Current and Future Burden of Osteoporosis in State Populations: Application to Florida in 2000 through 2025
2003
Psoriasis Pathogenesis and Treatment
2019 Standout
Immunology of Psoriasis
2014 Standout
The Epidemiology of Osteoporosis
1996
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025
2006 Standout
The epidemiology of osteoporosis. The oriental perspective in a world context.
1996
Biomechanics of Fracture Risk Prediction of the Hip and Spine by Quantitative Computed Tomography
1991
Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)
2005 StandoutNobel
Goats as an Osteopenic Animal Model
2001
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Risk factors for hip fracture in european women: The MEDOS study
1995
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
2003 Standout
Treatment of established osteoporosis: a systematic review and cost-utility analysis
2002
Medical Expenditures for the Treatment of Osteoporotic Fractures in the United States in 1995: Report from the National Osteoporosis Foundation
1997 Standout
The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop
2015 Standout
Risk Factors for Hip Fracture in White Women
1995 Standout
BMD at Multiple Sites and Risk of Fracture of Multiple Types: Long-Term Results From the Study of Osteoporotic Fractures
2003
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
2016 Standout
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
What have we learned in dermatology from the biologic therapies?
2006
Works of S. Phillips being referenced
The direct medical costs of osteoporosis for American women aged 45 and older, 1986
1988
Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: Results of a pilot, multicenter, multiple-dose, placebo-controlled study
2000